Beckers H J, De Kroon K E, Nuijts R M, Webers C A
University Eye Clinic, Maastricht, The Netherlands.
Doc Ophthalmol. 2000;100(1):43-7. doi: 10.1023/a:1002778319902.
The outcome of combined same-site phacoemulsification, posterior chamber lens implantation and trabeculectomy was retrospectively studied in patients with cataract and moderately controlled glaucoma, with a follow-up of at least 6 months. Primary phacotrabeculectomy without antimetabolites was performed in 74 patients. Mean IOP decreased from 22.8 to 14.3 mm Hg (35.3%). A maximum IOP of 19 mm Hg without glaucoma medication was reached in 66.2%. Mean logMAR visual acuity increased from 0.58 to 0.30. Primary phacotrabeculectomy has been shown to be a safe and effective procedure with good IOP control and rapid visual rehabilitation.
对患有白内障且青光眼病情得到适度控制的患者进行了回顾性研究，这些患者接受了同部位白内障超声乳化吸除术、后房型人工晶状体植入术和小梁切除术联合治疗，随访时间至少为6个月。74例患者接受了未使用抗代谢药物的原发性晶状体小梁切除术。平均眼压从22.8毫米汞柱降至14.3毫米汞柱（降幅35.3%）。66.2%的患者在未使用青光眼药物的情况下眼压最高达到19毫米汞柱。平均对数最小分辨角视力从0.58提高到0.30。原发性晶状体小梁切除术已被证明是一种安全有效的手术，能有效控制眼压并使视力快速恢复。
